KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Other financing activities (2016 - 2022)

Abbott Laboratories (ABT) has disclosed Other financing activities for 7 consecutive years, with $324.0 million as the latest value for Q1 2022.

  • Quarterly Other financing activities rose 6.58% to $324.0 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $324.0 million through Sep 2025, up 427.27% year-over-year, with the annual reading at -$82.0 million for FY2025, N/A changed from the prior year.
  • Other financing activities hit $324.0 million in Q1 2022 for Abbott Laboratories, up from -$536.0 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $324.0 million in Q1 2022 to a low of -$536.0 million in Q4 2021.
  • Historically, Other financing activities has averaged $110.9 million across 5 years, with a median of $105.5 million in 2019.
  • Biggest five-year swings in Other financing activities: crashed 79.65% in 2018 and later increased 24.08% in 2021.
  • Year by year, Other financing activities stood at $81.0 million in 2018, then grew by 4.94% to $85.0 million in 2019, then grew by 18.82% to $101.0 million in 2020, then tumbled by 630.69% to -$536.0 million in 2021, then skyrocketed by 160.45% to $324.0 million in 2022.
  • Business Quant data shows Other financing activities for ABT at $324.0 million in Q1 2022, -$536.0 million in Q4 2021, and $113.0 million in Q3 2021.